Pairing obinutuzumab with venetoclax in relapsed CLL
Details
Publication Year 2024-05,Volume 65,Issue #5,Page 543-545
Journal Title
Leukemia & Lymphoma
Publication Type
Commentary
Publisher
Taylor & Francis
Keywords
Humans; *Bridged Bicyclo Compounds, Heterocyclic/therapeutic use; *Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy; *Antibodies, Monoclonal, Humanized/therapeutic use/administration & dosage; *Sulfonamides/therapeutic use/administration & dosage; *Antineoplastic Combined Chemotherapy Protocols/therapeutic use/adverse effects; Male; Aged; Middle Aged; Treatment Outcome; Female; Neoplasm Recurrence, Local/drug therapy/pathology; Recurrence
Department(s)
Clinical Haematology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-07-17 07:24:17
Last Modified: 2024-07-17 07:24:25
An error has occurred. This application may no longer respond until reloaded. Reload 🗙